Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan for hospitalized adults with COVID-19
ISRCTN48734830Phase 4Terminated
- Sponsor
- Södersjukhuset
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of losartan in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Södersjukhuset. Primary endpoint: Primary composite endpoint. Started Aug 2020; status: terminated.
02
Drugs
losartan
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ISRCTN48734830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN48734830.